Cargando…
Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology
To provide practical guidelines for the cytopathologic diagnosis of malignant mesothelioma (MM). Cytopathologists involved in the International Mesothelioma Interest Group (IMIG) and the International Academy of Cytology (IAC), who have an interest in the field contributed to this update. Reference...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678521/ https://www.ncbi.nlm.nih.gov/pubmed/26681974 http://dx.doi.org/10.4103/1742-6413.170726 |
_version_ | 1782405456958849024 |
---|---|
author | Hjerpe, Anders Ascoli, Valeria Bedrossian, Carlos Boon, Mathilde Creaney, Jenette Davidson, Ben Dejmek, Annika Dobra, Katalin Fassina, Ambrogio Field, Andrew Firat, Pinar Kamei, Toshiaki Kobayashi, Tadao Michael, Claire W. Önder, Sevgen Segal, Amanda Vielh, Philippe |
author_facet | Hjerpe, Anders Ascoli, Valeria Bedrossian, Carlos Boon, Mathilde Creaney, Jenette Davidson, Ben Dejmek, Annika Dobra, Katalin Fassina, Ambrogio Field, Andrew Firat, Pinar Kamei, Toshiaki Kobayashi, Tadao Michael, Claire W. Önder, Sevgen Segal, Amanda Vielh, Philippe |
author_sort | Hjerpe, Anders |
collection | PubMed |
description | To provide practical guidelines for the cytopathologic diagnosis of malignant mesothelioma (MM). Cytopathologists involved in the International Mesothelioma Interest Group (IMIG) and the International Academy of Cytology (IAC), who have an interest in the field contributed to this update. Reference material includes peer-reviewed publications and textbooks. This article is the result of discussions during and after the IMIG 2012 conference in Boston, followed by thorough discussions during the 2013 IAC meeting in Paris. Additional contributions have been obtained from cytopathologists and scientists, who could not attend these meetings, with final discussions and input during the IMIG 2014 conference in cape town. During the previous IMIG biennial meetings, thorough discussions have resulted in published guidelines for the pathologic diagnosis of MM. However, previous recommendations have stated that the diagnosis of MM should be based on histological material only.[12] Accumulating evidence now indicates that the cytological diagnosis of MM supported by ancillary techniques is as reliable as that based on histopathology, although the sensitivity with cytology may be somewhat lower.[345] Recognizing that noninvasive diagnostic modalities benefit both the patient and the health system, future recommendations should include cytology as an accepted method for the diagnosis of this malignancy.[67] The article describes the consensus of opinions of the authors on how cytology together with ancillary testing can be used to establish a reliable diagnosis of MM. |
format | Online Article Text |
id | pubmed-4678521 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-46785212015-12-17 Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology Hjerpe, Anders Ascoli, Valeria Bedrossian, Carlos Boon, Mathilde Creaney, Jenette Davidson, Ben Dejmek, Annika Dobra, Katalin Fassina, Ambrogio Field, Andrew Firat, Pinar Kamei, Toshiaki Kobayashi, Tadao Michael, Claire W. Önder, Sevgen Segal, Amanda Vielh, Philippe Cytojournal Review Article To provide practical guidelines for the cytopathologic diagnosis of malignant mesothelioma (MM). Cytopathologists involved in the International Mesothelioma Interest Group (IMIG) and the International Academy of Cytology (IAC), who have an interest in the field contributed to this update. Reference material includes peer-reviewed publications and textbooks. This article is the result of discussions during and after the IMIG 2012 conference in Boston, followed by thorough discussions during the 2013 IAC meeting in Paris. Additional contributions have been obtained from cytopathologists and scientists, who could not attend these meetings, with final discussions and input during the IMIG 2014 conference in cape town. During the previous IMIG biennial meetings, thorough discussions have resulted in published guidelines for the pathologic diagnosis of MM. However, previous recommendations have stated that the diagnosis of MM should be based on histological material only.[12] Accumulating evidence now indicates that the cytological diagnosis of MM supported by ancillary techniques is as reliable as that based on histopathology, although the sensitivity with cytology may be somewhat lower.[345] Recognizing that noninvasive diagnostic modalities benefit both the patient and the health system, future recommendations should include cytology as an accepted method for the diagnosis of this malignancy.[67] The article describes the consensus of opinions of the authors on how cytology together with ancillary testing can be used to establish a reliable diagnosis of MM. Medknow Publications & Media Pvt Ltd 2015-11-30 /pmc/articles/PMC4678521/ /pubmed/26681974 http://dx.doi.org/10.4103/1742-6413.170726 Text en Copyright: © 2015 Hjerpe, et al.; Licensee Cytopathology Foundation Inc. http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Review Article Hjerpe, Anders Ascoli, Valeria Bedrossian, Carlos Boon, Mathilde Creaney, Jenette Davidson, Ben Dejmek, Annika Dobra, Katalin Fassina, Ambrogio Field, Andrew Firat, Pinar Kamei, Toshiaki Kobayashi, Tadao Michael, Claire W. Önder, Sevgen Segal, Amanda Vielh, Philippe Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology |
title | Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology |
title_full | Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology |
title_fullStr | Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology |
title_full_unstemmed | Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology |
title_short | Guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology |
title_sort | guidelines for cytopathologic diagnosis of epithelioid and mixed type malignant mesothelioma. complementary statement from the international mesothelioma interest group, also endorsed by the international academy of cytology and the papanicolaou society of cytopathology |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678521/ https://www.ncbi.nlm.nih.gov/pubmed/26681974 http://dx.doi.org/10.4103/1742-6413.170726 |
work_keys_str_mv | AT hjerpeanders guidelinesforcytopathologicdiagnosisofepithelioidandmixedtypemalignantmesotheliomacomplementarystatementfromtheinternationalmesotheliomainterestgroupalsoendorsedbytheinternationalacademyofcytologyandthepapanicolaousocietyofcytopathology AT ascolivaleria guidelinesforcytopathologicdiagnosisofepithelioidandmixedtypemalignantmesotheliomacomplementarystatementfromtheinternationalmesotheliomainterestgroupalsoendorsedbytheinternationalacademyofcytologyandthepapanicolaousocietyofcytopathology AT bedrossiancarlos guidelinesforcytopathologicdiagnosisofepithelioidandmixedtypemalignantmesotheliomacomplementarystatementfromtheinternationalmesotheliomainterestgroupalsoendorsedbytheinternationalacademyofcytologyandthepapanicolaousocietyofcytopathology AT boonmathilde guidelinesforcytopathologicdiagnosisofepithelioidandmixedtypemalignantmesotheliomacomplementarystatementfromtheinternationalmesotheliomainterestgroupalsoendorsedbytheinternationalacademyofcytologyandthepapanicolaousocietyofcytopathology AT creaneyjenette guidelinesforcytopathologicdiagnosisofepithelioidandmixedtypemalignantmesotheliomacomplementarystatementfromtheinternationalmesotheliomainterestgroupalsoendorsedbytheinternationalacademyofcytologyandthepapanicolaousocietyofcytopathology AT davidsonben guidelinesforcytopathologicdiagnosisofepithelioidandmixedtypemalignantmesotheliomacomplementarystatementfromtheinternationalmesotheliomainterestgroupalsoendorsedbytheinternationalacademyofcytologyandthepapanicolaousocietyofcytopathology AT dejmekannika guidelinesforcytopathologicdiagnosisofepithelioidandmixedtypemalignantmesotheliomacomplementarystatementfromtheinternationalmesotheliomainterestgroupalsoendorsedbytheinternationalacademyofcytologyandthepapanicolaousocietyofcytopathology AT dobrakatalin guidelinesforcytopathologicdiagnosisofepithelioidandmixedtypemalignantmesotheliomacomplementarystatementfromtheinternationalmesotheliomainterestgroupalsoendorsedbytheinternationalacademyofcytologyandthepapanicolaousocietyofcytopathology AT fassinaambrogio guidelinesforcytopathologicdiagnosisofepithelioidandmixedtypemalignantmesotheliomacomplementarystatementfromtheinternationalmesotheliomainterestgroupalsoendorsedbytheinternationalacademyofcytologyandthepapanicolaousocietyofcytopathology AT fieldandrew guidelinesforcytopathologicdiagnosisofepithelioidandmixedtypemalignantmesotheliomacomplementarystatementfromtheinternationalmesotheliomainterestgroupalsoendorsedbytheinternationalacademyofcytologyandthepapanicolaousocietyofcytopathology AT firatpinar guidelinesforcytopathologicdiagnosisofepithelioidandmixedtypemalignantmesotheliomacomplementarystatementfromtheinternationalmesotheliomainterestgroupalsoendorsedbytheinternationalacademyofcytologyandthepapanicolaousocietyofcytopathology AT kameitoshiaki guidelinesforcytopathologicdiagnosisofepithelioidandmixedtypemalignantmesotheliomacomplementarystatementfromtheinternationalmesotheliomainterestgroupalsoendorsedbytheinternationalacademyofcytologyandthepapanicolaousocietyofcytopathology AT kobayashitadao guidelinesforcytopathologicdiagnosisofepithelioidandmixedtypemalignantmesotheliomacomplementarystatementfromtheinternationalmesotheliomainterestgroupalsoendorsedbytheinternationalacademyofcytologyandthepapanicolaousocietyofcytopathology AT michaelclairew guidelinesforcytopathologicdiagnosisofepithelioidandmixedtypemalignantmesotheliomacomplementarystatementfromtheinternationalmesotheliomainterestgroupalsoendorsedbytheinternationalacademyofcytologyandthepapanicolaousocietyofcytopathology AT ondersevgen guidelinesforcytopathologicdiagnosisofepithelioidandmixedtypemalignantmesotheliomacomplementarystatementfromtheinternationalmesotheliomainterestgroupalsoendorsedbytheinternationalacademyofcytologyandthepapanicolaousocietyofcytopathology AT segalamanda guidelinesforcytopathologicdiagnosisofepithelioidandmixedtypemalignantmesotheliomacomplementarystatementfromtheinternationalmesotheliomainterestgroupalsoendorsedbytheinternationalacademyofcytologyandthepapanicolaousocietyofcytopathology AT vielhphilippe guidelinesforcytopathologicdiagnosisofepithelioidandmixedtypemalignantmesotheliomacomplementarystatementfromtheinternationalmesotheliomainterestgroupalsoendorsedbytheinternationalacademyofcytologyandthepapanicolaousocietyofcytopathology |